| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1999;99:2261-2267.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Department of Radiology (H.J.L., B.C.S., J.D., A.d.R.) and Cardiology (H.P.B., A.v.d.L., E.E.v.d.W.), Leiden (The Netherlands) University Medical Center.
Correspondence to Hildo J. Lamb, Department of Radiology (1C2S), Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. E-mail Lamb{at}RULLF2.Medfac.Leidenuniv.nl
BackgroundHypertension is an important clinical problem and is often accompanied by left ventricular (LV) hypertrophy and dysfunction. Whether the myocardial high-energy phosphate (HEP) metabolism is altered in human hypertensive heart disease and whether this is associated with LV dysfunction is not known.
Methods and ResultsEleven patients with hypertension and 13 age-matched healthy subjects were studied with magnetic resonance imaging at rest and with phosphorus-31 magnetic resonance spectroscopy at rest and during high-dose atropine-dobutamine stress. Hypertensive patients showed higher LV mass (98±28 g/m2) than healthy control subjects (73±13 g/m2, P<0.01). LV filling was impaired in patients, reflected by a decreased peak rate of wall thinning (PRWThn), E/A ratio, early peak filling rate, and early deceleration peak (all P<0.05), whereas systolic function was still normal. The myocardial phosphocreatine (PCr)/ATP ratio determined in patients at rest (1.20±0.18) and during stress (0.95±0.25) was lower than corresponding values obtained from healthy control subjects at rest (1.39±0.17, P<0.05) and during stress (1.16±0.18, P<0.05). The PCr/ATP ratio correlated significantly with PRWThn (r=-0.55, P<0.01), early deceleration peak (r=-0.56, P<0.01), and with the rate-pressure product (r=-0.53, P<0.001).
ConclusionsMyocardial HEP metabolism is altered in patients with hypertensive heart disease. In addition, there is an association between impaired LV diastolic function and altered myocardial HEP metabolism in humans. The level of myocardial PCr/ATP is most likely determined by the level of cardiac work load.
Key Words: magnetic resonance imaging spectroscopy hypertension diastole stress
This article has been cited by other articles:
![]() |
R. W. van der Meer, S. Hammer, H. J. Lamb, M. Frolich, M. Diamant, L. J. Rijzewijk, A. de Roos, J. A. Romijn, and J. W. A. Smit Effects of Short-Term High-Fat, High-Energy Diet on Hepatic and Myocardial Triglyceride Content in Healthy Men J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2702 - 2708. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. van der Meer, L. J. Rijzewijk, M. Diamant, S. Hammer, M. Schar, J. J. Bax, J. W.A. Smit, J. A. Romijn, A. de Roos, and H. J. Lamb The ageing male heart: myocardial triglyceride content as independent predictor of diastolic function Eur. Heart J., June 2, 2008; 29(12): 1516 - 1522. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Eisen Exercise Training and Myocardial Energetics in Patients With Heart Failure: When More Is Less J. Am. Coll. Cardiol., May 13, 2008; 51(19): 1892 - 1895. [Full Text] [PDF] |
||||
![]() |
H. Pavlopoulos, J. Grapsa, E. Stefanadi, V. Kamperidis, E. Philippou, D. Dawson, and P. Nihoyannopoulos The evolution of diastolic dysfunction in the hypertensive disease Eur J Echocardiogr, April 29, 2008; (2008) jen145v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Pavlopoulos, J. Grapsa, E. Stefanadi, E. Philippou, D. Dawson, and P. Nihoyannopoulos Is it only diastolic dysfunction? Segmental relaxation patterns and longitudinal systolic deformation in systemic hypertension Eur J Echocardiogr, April 4, 2008; (2008) jen133v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hammer, R. W. van der Meer, H. J. Lamb, M. Schar, A. de Roos, J. W. A. Smit, and J. A. Romijn Progressive Caloric Restriction Induces Dose-Dependent Changes in Myocardial Triglyceride Content and Diastolic Function in Healthy Men J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 497 - 503. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Perseghin, G. Ntali, F. De Cobelli, G. Lattuada, A. Esposito, E. Belloni, T. Canu, F. Costantino, F. Ragogna, P. Scifo, et al. Abnormal Left Ventricular Energy Metabolism in Obese Men With Preserved Systolic and Diastolic Functions Is Associated With Insulin Resistance Diabetes Care, June 1, 2007; 30(6): 1520 - 1526. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Neubauer The Failing Heart -- An Engine Out of Fuel N. Engl. J. Med., March 15, 2007; 356(11): 1140 - 1151. [Full Text] [PDF] |
||||
![]() |
C. S. Smith, P. A. Bottomley, S. P. Schulman, G. Gerstenblith, and R. G. Weiss Altered Creatine Kinase Adenosine Triphosphate Kinetics in Failing Hypertrophied Human Myocardium Circulation, September 12, 2006; 114(11): 1151 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. van der Laarse and E. E. van der Wall Myocardial contrast echocardiography: another discriminator of physiological and pathological left ventricular hypertrophy? Eur. Heart J., July 1, 2006; 27(13): 1517 - 1518. [Full Text] [PDF] |
||||
![]() |
P. S. Hees, J. L. Fleg, Z. A. Mirza, S. Ahmed, C. O. Siu, and E. P. Shapiro Effects of Normal Aging on Left Ventricular Lusitropic, Inotropic, and Chronotropic Responses to Dobutamine J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1440 - 1447. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Perseghin, P. Fiorina, F. De Cobelli, P. Scifo, A. Esposito, T. Canu, M. Danna, C. Gremizzi, A. Secchi, L. Luzi, et al. Cross-Sectional Assessment of the Effect of Kidney and Kidney-Pancreas Transplantation on Resting Left Ventricular Energy Metabolism in Type 1 Diabetic-Uremic Patients: A Phosphorous-31 Magnetic Resonance Spectroscopy Study J. Am. Coll. Cardiol., September 20, 2005; 46(6): 1085 - 1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gonzalez, M. A Fortuno, R. Querejeta, S. Ravassa, B. Lopez, N. Lopez, and J. Diez Cardiomyocyte apoptosis in hypertensive cardiomyopathy Cardiovasc Res, September 1, 2003; 59(3): 549 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Diamant, H. J. Lamb, Y. Groeneveld, E. L. Endert, J. W. A. Smit, J. J. Bax, J. A. Romijn, A. de Roos, and J. K. Radder Diastolic dysfunction is associatedwith altered myocardial metabolism inasymptomatic normotensive patientswith well-controlled type 2 diabetes mellitus J. Am. Coll. Cardiol., July 16, 2003; 42(2): 328 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Crilley, E. A. Boehm, E. Blair, B. Rajagopalan, A. M. Blamire, P. Styles, W. J. McKenna, I. Ostman-Smith, K. Clarke, and H. Watkins Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1776 - 1782. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Lamb, H. P. Beyerbacht, A. de Roos, A. van der Laarse, H. W. Vliegen, F. Leujes, J. J. Bax, and E. E. van der Wall Left ventricular remodeling early after aortic valve replacement: differential effects on diastolic function in aortic valve stenosis and aortic regurgitation J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2182 - 2188. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Beer, T. Seyfarth, J.o. Sandstede, W. Landschutz, C. Lipke, H. Kostler, M. von Kienlin, K. Harre, D. Hahn, and S. Neubauer Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with 31P-SLOOP magnetic resonance spectroscopy J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1267 - 1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. van der Laarse Hypothesis: troponin degradation is one of the factors responsible for deterioration of left ventricular function in heart failure Cardiovasc Res, October 1, 2002; 56(1): 8 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Kalweit, J. D. Schipke, E. Godehardt, and E. Gams Changes in coronary vessel resistance during postischemic reperfusion and effectiveness of nitroglycerin J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 1011 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. A. Smit, Y. J. H. Janssen, H. J. Lamb, E. E. van der Wall, M. P. M. Stokkel, E. Viergever, N. R. Biermasz, J. J. Bax, H. W. Vliegen, A. de Roos, et al. Six Months of Recombinant Human GH Therapy in Patients with Ischemic Cardiac Failure Does Not Influence Left Ventricular Function and Mass J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4638 - 4643. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Beyerbacht, H. J. Lamb, A. van der Laarse, H. W. Vliegen, F. Leujes, M. G. Hazekamp, A. de Roos, and E. E. van der Wall Aortic Valve Replacement in Patients with Aortic Valve Stenosis Improves Myocardial Metabolism and Diastolic Function Radiology, June 1, 2001; 219(3): 637 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Crilley, E. A. Boehm, B. Rajagopalan, A. M. Blamire, P. Styles, F. Muntoni, D. Hilton-Jones, and K. Clarke Magnetic resonance spectroscopy evidence of abnormal cardiac energetics in Xp21 muscular dystrophy J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1953 - 1958. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Segers, N. Stergiopulos, J. J. Schreuder, B. E. Westerhof, and N. Westerhof Left ventricular wall stress normalization in chronic pressure-overloaded heart: a mathematical model study Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1120 - H1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Lorell and B. A. Carabello Left Ventricular Hypertrophy : Pathogenesis, Detection, and Prognosis Circulation, July 25, 2000; 102(4): 470 - 479. [Full Text] [PDF] |
||||
![]() |
L. Mandinov, F. R. Eberli, C. Seiler, and O. M. Hess Diastolic heart failure Cardiovasc Res, March 1, 2000; 45(4): 813 - 825. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |